Literature DB >> 16109999

Ecteinascidin-743 (ET-743): early test or effective treatment in soft tissue sarcomas?

Jaap Verweij.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16109999     DOI: 10.1200/JCO.2005.04.905

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  2 in total

1.  Population pharmacokinetic meta-analysis of trabectedin (ET-743, Yondelis) in cancer patients.

Authors:  Juan Jose Perez-Ruixo; Peter Zannikos; Sarapee Hirankarn; Kim Stuyckens; Elizabeth A Ludwig; Arturo Soto-Matos; Luis Lopez-Lazaro; Joel S Owen
Journal:  Clin Pharmacokinet       Date:  2007       Impact factor: 6.447

2.  The use of positron emission tomography in soft tissue sarcoma patients under therapy with trabectedin.

Authors:  Bernd Kasper; Thomas Schmitt; Patrick Wuchter; Antonia Dimitrakopoulou-Strauss; Anthony D Ho; Gerlinde Egerer
Journal:  Mar Drugs       Date:  2009-07-17       Impact factor: 5.118

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.